Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
MAP3K14
Introduction
Mitogen-activated protein kinase kinase kinase 14 also known as NF-kappa-B-inducing kinase (NIK) is an enzyme that in humans is encoded by the MAP3K14 gene.[1][2]
Function
Function
This gene encodes mitogen-activated protein kinase kinase kinase 14, NIK, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-κB activity. It is a critical kinase of the alternative NF-κB activation pathway. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-κB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor.[2]
References
References
- ↑ 1.0 1.1 Malinin NL, Boldin MP, Kovalenko AV, Wallach D (March 1997). “MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1”. Nature. 385 (6616): 540–4. doi:10.1038/385540a0. PMID 9020361.
- ↑ 2.0 2.1 “Entrez Gene: MAP3K14 mitogen-activated protein kinase kinase kinase 14”.
- ↑ 3.0 3.1 3.2 Luftig MA, Cahir-McFarland E, Mosialos G, Kieff E (May 2001). “Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40”. J. Biol. Chem. 276 (18): 14602–6. doi:10.1074/jbc.C100103200. PMID 11278268.
- ↑ Régnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M (July 1997). “Identification and characterization of an IkappaB kinase”. Cell. 90 (2): 373–83. doi:10.1016/S0092-8674(00)80344-X. PMID 9244310.
- ↑ Xiao G, Sun SC (July 2000). “Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain”. J. Biol. Chem. 275 (28): 21081–5. doi:10.1074/jbc.M002552200. PMID 10887201.
- ↑ Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K (March 1999). “The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway”. Nature. 398 (6724): 252–6. doi:10.1038/18465. PMID 10094049.
- ↑ Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV (October 1997). “IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK”. Science. 278 (5339): 866–9. doi:10.1126/science.278.5339.866. PMID 9346485.
Further reading
Further reading
- Régnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M (1997). “Identification and characterization of an IkappaB kinase”. Cell. 90 (2): 373–83. doi:10.1016/S0092-8674(00)80344-X. PMID 9244310.
- Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M (1997). “Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of Nuclear Factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2”. Proc. Natl. Acad. Sci. U.S.A. 94 (18): 9792–6. doi:10.1073/pnas.94.18.9792. PMC 23270. PMID 9275204.
- Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV (1997). “IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK”. Science. 278 (5339): 866–9. doi:10.1126/science.278.5339.866. PMID 9346485.
- Ling L, Cao Z, Goeddel DV (1998). “NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176”. Proc. Natl. Acad. Sci. U.S.A. 95 (7): 3792–7. doi:10.1073/pnas.95.7.3792. PMC 19916. PMID 9520446.
- Lee FS, Peters RT, Dang LC, Maniatis T (1998). “MEKK1 activates both IκB kinase α and IκB kinase β”. Proc. Natl. Acad. Sci. U.S.A. 95 (16): 9319–24. doi:10.1073/pnas.95.16.9319. PMC 21336. PMID 9689078.
- Lin X, Mu Y, Cunningham ET, Marcu KB, Geleziunas R, Greene WC (1998). “Molecular Determinants of NF-κB-Inducing Kinase Action”. Mol. Cell. Biol. 18 (10): 5899–907. doi:10.1128/mcb.18.10.5899. PMC 109176. PMID 9742107.
- Cohen L, Henzel WJ, Baeuerle PA (1998). “IKAP is a scaffold protein of the IkappaB kinase complex”. Nature. 395 (6699): 292–6. doi:10.1038/26254. PMID 9751059.
- Aronsson FC, Magnusson P, Andersson B, Karsten SL, Shibasaki Y, Lendon CL, Goate AM, Brookes AJ (1998). “The NIK protein kinase and C17orf1 genes: chromosomal mapping, gene structures and mutational screening in frontotemporal dementia and parkinsonism linked to chromosome 17”. Hum. Genet. 103 (3): 340–5. doi:10.1007/s004390050827. PMID 9799091.
- Nemoto S, DiDonato JA, Lin A (1998). “Coordinate Regulation of IκB Kinases by Mitogen-Activated Protein Kinase Kinase Kinase 1 and NF-κB-Inducing Kinase”. Mol. Cell. Biol. 18 (12): 7336–43. doi:10.1128/mcb.18.12.7336. PMC 109315. PMID 9819420.
- Li Y, Kang J, Friedman J, Tarassishin L, Ye J, Kovalenko A, Wallach D, Horwitz MS (1999). “Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis”. Proc. Natl. Acad. Sci. U.S.A. 96 (3): 1042–7. doi:10.1073/pnas.96.3.1042. PMC 15347. PMID 9927690.
- Lallena MJ, Diaz-Meco MT, Bren G, Payá CV, Moscat J (1999). “Activation of IκB Kinase β by Protein Kinase C Isoforms”. Mol. Cell. Biol. 19 (3): 2180–8. PMC 84010. PMID 10022904.
- Lin X, Cunningham ET, Mu Y, Geleziunas R, Greene WC (1999). “The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases”. Immunity. 10 (2): 271–80. doi:10.1016/S1074-7613(00)80027-8. PMID 10072079.
- Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K (1999). “The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway”. Nature. 398 (6724): 252–6. doi:10.1038/18465. PMID 10094049.
- Delhase M, Hayakawa M, Chen Y, Karin M (1999). “Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation”. Science. 284 (5412): 309–13. doi:10.1126/science.284.5412.309. PMID 10195894.
- Hu WH, Johnson H, Shu HB (1999). “Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways”. J. Biol. Chem. 274 (43): 30603–10. doi:10.1074/jbc.274.43.30603. PMID 10521444.
- Yamamoto Y, Yin MJ, Gaynor RB (2000). “IκB Kinase α (IKKα) Regulation of IKKβ Kinase Activity”. Mol. Cell. Biol. 20 (10): 3655–66. doi:10.1128/MCB.20.10.3655-3666.2000. PMC 85658. PMID 10779355.
- Xiao G, Sun SC (2000). “Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain”. J. Biol. Chem. 275 (28): 21081–5. doi:10.1074/jbc.M002552200. PMID 10887201.
- Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L (2000). “Activation of the NF-kappaB pathway by caspase 8 and its homologs”. Oncogene. 19 (39): 4451–60. doi:10.1038/sj.onc.1203812. PMID 11002417.
- Kumar A, Eby MT, Sinha S, Jasmin A, Chaudhary PM (2001). “The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A”. J. Biol. Chem. 276 (4): 2668–77. doi:10.1074/jbc.M008356200. PMID 11035039.